Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$35.86 - $46.5 $221,650 - $287,416
-6,181 Reduced 42.88%
8,233 $334,000
Q4 2022

Jan 23, 2023

BUY
$35.49 - $56.15 $28,888 - $45,706
814 Added 5.99%
14,414 $0
Q3 2022

Oct 24, 2022

BUY
$43.76 - $68.97 $2,363 - $3,724
54 Added 0.4%
13,600 $651,000
Q2 2022

Aug 02, 2022

BUY
$53.22 - $123.09 $32,783 - $75,823
616 Added 4.76%
13,546 $802,000
Q1 2022

Apr 20, 2022

SELL
$101.89 - $150.09 $24,453 - $36,021
-240 Reduced 1.82%
12,930 $1.5 Million
Q4 2021

Jan 31, 2022

BUY
$118.18 - $153.21 $47,272 - $61,284
400 Added 3.13%
13,170 $1.98 Million
Q3 2021

Nov 05, 2021

BUY
$93.51 - $129.4 $560,685 - $775,882
5,996 Added 88.51%
12,770 $1.52 Million
Q2 2021

Aug 12, 2021

BUY
$77.0 - $100.19 $85,162 - $110,810
1,106 Added 19.51%
6,774 $660,000
Q1 2021

May 10, 2021

BUY
$81.28 - $104.34 $13,086 - $16,798
161 Added 2.92%
5,668 $500,000
Q4 2020

Feb 11, 2021

SELL
$86.4 - $121.75 $259 - $365
-3 Reduced 0.05%
5,507 $527,000
Q3 2020

Oct 26, 2020

BUY
$95.43 - $116.09 $12,883 - $15,672
135 Added 2.51%
5,510 $625,000
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $322,768 - $531,695
5,375 New
5,375 $532,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.26B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.